{"id":"NCT03571672","sponsor":"Lantheus Medical Imaging","briefTitle":"DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY","officialTitle":"A Phase III, Open-Label, Multicenter Trial to Evaluate Ejection Fraction, End-Diastolic and End-Systolic Volumes, by Unenhanced and DEFINITY®-Enhanced 2D-Echo and Magnetic Resonance Imaging","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-10-24","primaryCompletion":"2019-08-30","completion":"2019-08-30","firstPosted":"2018-06-27","resultsPosted":"2020-12-17","lastUpdate":"2020-12-17"},"enrollment":153,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Cardiac Disease"],"interventions":[{"type":"DRUG","name":"DEFINITY","otherNames":[]}],"arms":[{"label":"DEFINITY","type":"EXPERIMENTAL"}],"summary":"This is a Phase 3, prospective, open-label, multicenter study to evaluate Left Ventricular Ejection Fraction (LVEF) measurement accuracy and reproducibility of DEFINITY® contrast-enhanced and unenhanced echocardiography as compared with non-contrast cardiac magnetic resonance imaging (CMR) used as the truth standard.","primaryOutcome":{"measure":"Absolute Value of LVEF Percentage Differences From CMR by Blinded Reader","timeFrame":"Up to 30 days between day of echocardiograms and CMR imaging","effectByArm":[{"arm":"Blinded Reader 1","deltaMin":6.1,"sd":5.319},{"arm":"Blinded Reader 2","deltaMin":6.38,"sd":5.227},{"arm":"Blinded Reader 3","deltaMin":4.93,"sd":4.288}],"pValues":[{"comp":"OG000","p":"0.868"},{"comp":"OG001","p":"0.606"},{"comp":"OG002","p":"0.224"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":9,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":153},"commonTop":[]}}